Mercy Oncology and Hematology - Clayton-Clarkson is a clinical research site located in Ballwin, Missouri, United States 63011.
Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.
Mercy Oncology and Hematology - Clayton-Clarkson has participated in 101 clinical trials with 94 currently active.
Therapeutic areas: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.
Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Missouri · View every site in Ballwin
Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mercy Oncology and Hematology - Clayton-Clarkson has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mercy Oncology and Hematology - Clayton-Clarkson has 101 clinical trials on record, with 94 currently active. Their work covers Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.
Mercy Oncology and Hematology - Clayton-Clarkson has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.